Lv11
20 积分 2021-09-05 加入
IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 study
1小时前
待确认
CAR T Cell Toxicities and Emerging Treatment Strategies
4个月前
已完结
Pathology associated with human CAR T cell administration in NOD.Cg- Prkdc scid Il2rg tm1Wjl /SzJ (NSG) mice: A retrospective analysis
4个月前
已完结
Clinical and Cytokine Features of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome
4个月前
已完结
Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells
5个月前
已完结
Chimeric antigen receptor T-cell therapy and bispecific antibody sequence for large B-cell lymphoma: a systematic review and meta-analysis
6个月前
已完结
Intra-Tumor Injection of CAR-Engineered NK Cells Induces Tumor Regression and Protection Against Tumor Re-Challenge
8个月前
已关闭
IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 study
8个月前
已完结
Early versus standard management of chimeric antigen receptor therapy toxicities and management's impact on safety and efficacy
9个月前
已完结
Improving the safety of CAR-T cell therapy by controlling CRS-related coagulopathy
9个月前
已完结
皖公网安备34019202002308
